Fluorescence polarization immunoassay, IV Determination of phenytoin and phenobarbital in human serum and plasma

M. Lu-Steffes, G. W. Pittluck, M. E. Jolley, H. N. Panas, D. L. Olive, C. H. Wang, D. D. Nystrom, C. L. Keegan, T. P. Davis, S. D. Stroupe

Research output: Contribution to journalArticlepeer-review

57 Scopus citations

Abstract

Fluorescence polarization immunoassays for phenytoin and phenobarbital in human serum or plasma are described and shown to be clinically useful. No sample pretreatment, extraction, or phase separation is required. A determination can be made with less than 20 μL of sample in 15 min, with incubation at ambient temperature. Abnormal concentrations of protein, lipid, hemoglobin, or bilirubin do not interfere. In addition, drug metabolites and commonly co-administered drugs do not affect the assay results at clinically significant concentrations. Analytical recoveries of each of the two anticonvulsant drugs from serum averaged 101%. Between-assay CVs were <6.5%, with sensitivities of 0.5 mg/L. Comparison of this method with 'high-performance' liquid chromatography, homogeneous enzyme immunoassay, and radioimmunoassay for phenytoin determinations yielded correlations of 0.99, 0.98, and 0.99, respectively. Similar comparison studies for phenobarbital yielded correlation coefficients of 0.99, 0.98, and 0.99, respectively.

Original languageEnglish (US)
Pages (from-to)2278-2282
Number of pages5
JournalUnknown Journal
Volume28
Issue number11
DOIs
StatePublished - 1982

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Fluorescence polarization immunoassay, IV Determination of phenytoin and phenobarbital in human serum and plasma'. Together they form a unique fingerprint.

Cite this